<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>NEUROSURGERY BLOG</title>
	<atom:link href="http://neurocirurgiabr.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://neurocirurgiabr.com</link>
	<description></description>
	<lastBuildDate>Tue, 21 May 2013 00:14:56 +0000</lastBuildDate>
	<language>pt-PT</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5</generator>
		<item>
		<title>Music interventions for improving psychological and physical outcomes in cancer patients.</title>
		<link>http://neurocirurgiabr.com/music-interventions-for-improving-psychological-and-physical-outcomes-in-cancer-patients/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=music-interventions-for-improving-psychological-and-physical-outcomes-in-cancer-patients</link>
		<comments>http://neurocirurgiabr.com/music-interventions-for-improving-psychological-and-physical-outcomes-in-cancer-patients/#comments</comments>
		<pubDate>Tue, 21 May 2013 00:13:59 +0000</pubDate>
		<dc:creator>Julio Pereira, MD</dc:creator>
				<category><![CDATA[Brain Tumor]]></category>

		<guid isPermaLink="false">http://neurocirurgiabr.com/?p=5149</guid>
		<description><![CDATA[<p>&#160; Cochrane Database Syst Rev. 2011 Aug 10;(8):CD006911. doi: 10.1002/14651858.CD006911.pub2. Music interventions for improving psychological and physical outcomes in cancer patients. (CLICK HERE) &#160; Bradt J, Dileo C, Grocke D, Magill L. Source Department of Creative Arts Therapies, College of Nursing and Health Professions, Drexel University, 1505 Race Street, rm 1041, Philadelphia, PA, USA, 19102. [...]</p><p>The post <a href="http://neurocirurgiabr.com/music-interventions-for-improving-psychological-and-physical-outcomes-in-cancer-patients/">Music interventions for improving psychological and physical outcomes in cancer patients.</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></description>
				<content:encoded><![CDATA[<p>&nbsp;</p>
<div><span style="color: #0000ff;">Cochrane Database Syst Rev. 2011 Aug 10;(8):CD006911. doi: 10.1002/14651858.CD006911.pub2.</span></div>
<h1><span style="color: #0000ff;">Music interventions for improving psychological and physical outcomes in cancer patients. (CLICK HERE)<br />
</span></h1>
<p>&nbsp;</p>
<div><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Bradt%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21833957">Bradt J</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Dileo%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21833957">Dileo C</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Grocke%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21833957">Grocke D</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Magill%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21833957">Magill L</a>.</div>
<div>
<h3>Source</h3>
<p>Department of Creative Arts Therapies, College of Nursing and Health Professions, Drexel University, 1505 Race Street, rm 1041, Philadelphia, PA, USA, 19102.</p>
</div>
<div>
<h3>Abstract</h3>
<div>
<h4>BACKGROUND:</h4>
<p>Having cancer may result in extensive emotional, physical and social suffering. Music interventions have been used to alleviate symptoms and treatment side effects in cancer patients.</p>
<h4>OBJECTIVES:</h4>
<p>To compare the effects of music therapy or music medicine interventions and standard care with standard care alone, or standard care and other interventions in patients with cancer.</p>
<h4>SEARCH STRATEGY:</h4>
<p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2010, Issue 10), MEDLINE, EMBASE, CINAHL, PsycINFO, LILACS, Science Citation Index, CancerLit, www.musictherapyworld.net, CAIRSS, Proquest Digital Dissertations, ClinicalTrials.gov, Current Controlled Trials, and the National Research Register. All databases were searched from their start date to September 2010. We handsearched music therapy journals and reference lists and contacted experts. There was no language restriction.</p>
<h4>SELECTION CRITERIA:</h4>
<p>We included all randomized controlled trials (RCTs) and quasi-randomized trials of music interventions for improving psychological and physical outcomes in patients with cancer. Participants undergoing biopsy and aspiration for diagnostic purposes were excluded.</p>
<h4>DATA COLLECTION AND ANALYSIS:</h4>
<p>Two review authors independently extracted the data and assessed the risk of bias. Where possible, results were presented in meta analyses using mean differences and standardized mean differences. Post-test scores were used. In cases of significant baseline difference, we used change scores.</p>
<h4>MAIN RESULTS:</h4>
<p>We included 30 trials with a total of 1891 participants. We included music therapy interventions, offered by trained music therapists, as well as listening to pre-recorded music, offered by medical staff. The results suggest that music interventions may have a beneficial effect on anxiety in people with cancer, with a reported average anxiety reduction of 11.20 units (95% confidence interval (CI) -19.59 to -2.82, P = 0.009) on the STAI-S scale and -0.61 standardized units (95% CI -0.97 to -0.26, P = 0.0007) on other anxiety scales. Results also suggested a positive impact on mood (standardised mean difference (SMD) = 0.42, 95% CI 0.03 to 0.81, P = 0.03), but no support was found for depression.Music interventions may lead to small reductions in heart rate, respiratory rate, and blood pressure. A moderate pain-reducing effect was found (SMD = -0.59, 95% CI -0.92 to -0.27, P = 0.0003), but no strong evidence was found for enhancement of fatigue or physical status. The pooled estimate of two trials suggested a beneficial effect of music therapy on patients&#8217; quality of life (QoL) (SMD = 1.02, 95% CI 0.58 to 1.47, P = 0.00001).No conclusions could be drawn regarding the effect of music interventions on distress, body image, oxygen saturation level, immunologic functioning, spirituality, and communication outcomes.Seventeen trials used listening to pre-recorded music and 13 trials used music therapy interventions that actively engaged the patients. Not all studies included the same outcomes and due to the small number of studies per outcome, we could not compare the effectiveness of music medicine interventions with that of music therapy interventions.</p>
<h4>AUTHORS&#8217; CONCLUSIONS:</h4>
<p>This systematic review indicates that music interventions may have beneficial effects on anxiety, pain, mood, and QoL in people with cancer. Furthermore, music may have a small effect on heart rate, respiratory rate, and blood pressure. Most trials were at high risk of bias and, therefore, these results need to be interpreted with caution.</p>
</div>
</div>
<p>The post <a href="http://neurocirurgiabr.com/music-interventions-for-improving-psychological-and-physical-outcomes-in-cancer-patients/">Music interventions for improving psychological and physical outcomes in cancer patients.</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://neurocirurgiabr.com/music-interventions-for-improving-psychological-and-physical-outcomes-in-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>individual music therapy for agitation in dementia: an exploratory randomized controlled trial.</title>
		<link>http://neurocirurgiabr.com/ividual-music-therapy-for-agitation-in-dementia-an-exploratory-randomized-controlled-trial/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ividual-music-therapy-for-agitation-in-dementia-an-exploratory-randomized-controlled-trial</link>
		<comments>http://neurocirurgiabr.com/ividual-music-therapy-for-agitation-in-dementia-an-exploratory-randomized-controlled-trial/#comments</comments>
		<pubDate>Tue, 21 May 2013 00:11:48 +0000</pubDate>
		<dc:creator>Julio Pereira, MD</dc:creator>
				<category><![CDATA[Neurology]]></category>

		<guid isPermaLink="false">http://neurocirurgiabr.com/?p=5145</guid>
		<description><![CDATA[<p>Aging Ment Health. 2013 Apr 27. [Epub ahead of print] Individual music therapy for agitation in dementia: an exploratory randomized controlled trial. (CLICK HERE) Ridder HM, Stige B, Qvale LG, Gold C. Source a Doctoral Programme in Music Therapy, Department of Communication &#38; Psychology , Aalborg University , Aalborg Øst , Denmark. Abstract Objectives: Agitation [...]</p><p>The post <a href="http://neurocirurgiabr.com/ividual-music-therapy-for-agitation-in-dementia-an-exploratory-randomized-controlled-trial/">individual music therapy for agitation in dementia: an exploratory randomized controlled trial.</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></description>
				<content:encoded><![CDATA[<div><a title="Aging &amp; mental health." role="menuitem" href="http://www.ncbi.nlm.nih.gov/pubmed/23621805#">Aging Ment Health.</a> 2013 Apr 27. [Epub ahead of print]</div>
<h1><span style="color: #0000ff;">Ind<a href="http://www.tandfonline.com/doi/abs/10.1080/13607863.2013.790926?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed#.UZq7soK2t9k"><span style="color: #0000ff;">ividual music therapy for agitation in dementia: an exploratory randomized controlled trial. (CLICK HERE) </span></a></span></h1>
<div><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Ridder%20HM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23621805">Ridder HM</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Stige%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23621805">Stige B</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Qvale%20LG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23621805">Qvale LG</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Gold%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23621805">Gold C</a>.</div>
<div>
<h3>Source</h3>
<p>a Doctoral Programme in Music Therapy, Department of Communication &amp; Psychology , Aalborg University , Aalborg Øst , Denmark.</p>
</div>
<div>
<h3>Abstract</h3>
<div>
<p>Objectives: Agitation in nursing home residents with dementia leads to increase in psychotropic medication, decrease in quality of life, and to patient distress and caregiver burden. Music therapy has previously been found effective in treatment of agitation in dementia care but studies have been methodologically insufficient. The aim of this study was to examine the effect of individual music therapy on agitation in persons with moderate/severe dementia living in nursing homes, and to explore its effect on psychotropic medication and quality of life. Method: In a crossover trial, 42 participants with dementia were randomized to a sequence of six weeks of individual music therapy and six weeks of standard care. Outcome measures included agitation, quality of life and medication. Results: Agitation disruptiveness increased during standard care and decreased during music therapy. The difference at -6.77 (95% CI (confidence interval): -12.71, -0.83) was significant (p = 0.027), with a medium effect size (0.50). The prescription of psychotropic medication increased significantly more often during standard care than during music therapy (p = 0.02). Conclusion: This study shows that six weeks of music therapy reduces agitation disruptiveness and prevents medication increases in people with dementia. The positive trends in relation to agitation frequency and quality of life call for further research with a larger sample.</p>
</div>
</div>
<dl>
<dt>PMID:</dt>
<dd>23621805</dd>
<dd>[PubMed - as supplied by publisher]</dd>
</dl>
<p>The post <a href="http://neurocirurgiabr.com/ividual-music-therapy-for-agitation-in-dementia-an-exploratory-randomized-controlled-trial/">individual music therapy for agitation in dementia: an exploratory randomized controlled trial.</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://neurocirurgiabr.com/ividual-music-therapy-for-agitation-in-dementia-an-exploratory-randomized-controlled-trial/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Simpósio de Abertura do Hospital Estadual do Cérebro Paulo Niemeyer</title>
		<link>http://neurocirurgiabr.com/simposio-de-abertura-do-hospital-estadual-do-cerebro-paulo-niemeyer/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=simposio-de-abertura-do-hospital-estadual-do-cerebro-paulo-niemeyer</link>
		<comments>http://neurocirurgiabr.com/simposio-de-abertura-do-hospital-estadual-do-cerebro-paulo-niemeyer/#comments</comments>
		<pubDate>Mon, 20 May 2013 16:47:09 +0000</pubDate>
		<dc:creator>Julio Pereira, MD</dc:creator>
				<category><![CDATA[Education]]></category>

		<guid isPermaLink="false">http://neurocirurgiabr.com/?p=5140</guid>
		<description><![CDATA[<p></p><p>The post <a href="http://neurocirurgiabr.com/simposio-de-abertura-do-hospital-estadual-do-cerebro-paulo-niemeyer/">Simpósio de Abertura do Hospital Estadual do Cérebro Paulo Niemeyer</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></description>
				<content:encoded><![CDATA[<p><a href="http://neurocirurgiabr.com/simposio-de-abertura-do-hospital-estadual-do-cerebro-paulo-niemeyer/simposiohecnp-2fotos/" rel="attachment wp-att-5141"><img class="alignnone size-full wp-image-5141" alt="simposiohecnp-2fotos" src="http://neurocirurgiabr.com/wp-content/uploads/2013/05/simposiohecnp-2fotos.gif" width="1000" height="1496" /></a></p>
<p>The post <a href="http://neurocirurgiabr.com/simposio-de-abertura-do-hospital-estadual-do-cerebro-paulo-niemeyer/">Simpósio de Abertura do Hospital Estadual do Cérebro Paulo Niemeyer</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://neurocirurgiabr.com/simposio-de-abertura-do-hospital-estadual-do-cerebro-paulo-niemeyer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Emergency neurological life support: acute ischemic stroke.</title>
		<link>http://neurocirurgiabr.com/emergency-neurological-life-support-acute-ischemic-stroke/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=emergency-neurological-life-support-acute-ischemic-stroke</link>
		<comments>http://neurocirurgiabr.com/emergency-neurological-life-support-acute-ischemic-stroke/#comments</comments>
		<pubDate>Mon, 20 May 2013 00:57:22 +0000</pubDate>
		<dc:creator>Julio Pereira, MD</dc:creator>
				<category><![CDATA[Neurology]]></category>
		<category><![CDATA[Vascular]]></category>

		<guid isPermaLink="false">http://neurocirurgiabr.com/?p=5134</guid>
		<description><![CDATA[<p>Neurocrit Care. 2012 Sep;17 Suppl 1:S29-36. &#160; Emergency neurological life support: acute ischemic stroke. &#160; Gross H, Sung G, Weingart SD, Smith WS. Source Department of Emergency Medicine, Medical College of Georgia, Georgia Health Sciences University, Augusta, GA, USA. hgross@georgiahealth.edu Abstract Acute ischemic stroke is a neurological emergency that can be treated with time-sensitive interventions, [...]</p><p>The post <a href="http://neurocirurgiabr.com/emergency-neurological-life-support-acute-ischemic-stroke/">Emergency neurological life support: acute ischemic stroke.</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></description>
				<content:encoded><![CDATA[<div><a title="Neurocritical care." role="menuitem" href="http://www.ncbi.nlm.nih.gov/pubmed/22948888#">Neurocrit Care.</a> 2012 Sep;17 Suppl 1:S29-36.</div>
<p>&nbsp;</p>
<h1><span style="color: #3366ff;">Emergency neurological life support: acute ischemic stroke.</span></h1>
<p>&nbsp;</p>
<div><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Gross%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22948888">Gross H</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Sung%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22948888">Sung G</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Weingart%20SD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22948888">Weingart SD</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Smith%20WS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22948888">Smith WS</a>.</div>
<div>
<h3>Source</h3>
<p>Department of Emergency Medicine, Medical College of Georgia, Georgia Health Sciences University, Augusta, GA, USA. hgross@georgiahealth.edu</p>
</div>
<div>
<h3>Abstract</h3>
<div>
<p>Acute ischemic stroke is a neurological emergency that can be treated with time-sensitive interventions, including intravenous thrombolysis and endovascular approaches. Extensive study has demonstrated that rapid assessment and treatment are essential to improving neurological outcome. For this reason, acute ischemic stroke was chosen as an Emergency Neurological Life Support protocol. The protocol focuses on the first hour following the onset of neurological deficit.</p>
</div>
</div>
<dl>
<dt>PMID:</dt>
<dd>22948888</dd>
<dd>[PubMed - indexed for MEDLINE]</dd>
</dl>
<p>The post <a href="http://neurocirurgiabr.com/emergency-neurological-life-support-acute-ischemic-stroke/">Emergency neurological life support: acute ischemic stroke.</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://neurocirurgiabr.com/emergency-neurological-life-support-acute-ischemic-stroke/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hydrocephalus after arteriovenous malformation rupture</title>
		<link>http://neurocirurgiabr.com/hydrocephalus-after-arteriovenous-malformation-rupture/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=hydrocephalus-after-arteriovenous-malformation-rupture</link>
		<comments>http://neurocirurgiabr.com/hydrocephalus-after-arteriovenous-malformation-rupture/#comments</comments>
		<pubDate>Sun, 19 May 2013 14:17:21 +0000</pubDate>
		<dc:creator>Julio Pereira, MD</dc:creator>
				<category><![CDATA[Vascular]]></category>

		<guid isPermaLink="false">http://neurocirurgiabr.com/?p=5131</guid>
		<description><![CDATA[<p>Neurosurgical Focus May 2013 / Vol. 34 / No. 5 / Page E11 Article Hydrocephalus after arteriovenous malformation rupture Bradley A. Gross, M.D., Pui Man Rosalind Lai, B.A., and Rose Du, M.D., Ph.D. Department of Neurological Surgery, Brigham and Women&#8217;s Hospital and Harvard Medical School, Boston, Massachusetts Abbreviations used in this paper: AVM = arteriovenous [...]</p><p>The post <a href="http://neurocirurgiabr.com/hydrocephalus-after-arteriovenous-malformation-rupture/">Hydrocephalus after arteriovenous malformation rupture</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></description>
				<content:encoded><![CDATA[<p><a href="http://thejns.org/doi/abs/10.3171/2013.2.FOCUS12368"></p>
<div>
<h2><span style="color: #0000ff;">Neurosurgical Focus</span></h2>
<p><span style="color: #0000ff;"><em>May 2013</em> / Vol. 34 / No. 5 / Page E11</span></div>
<p><span style="color: #0000ff;"><strong>Article</strong></span></p>
<h3><span style="color: #0000ff;">Hydrocephalus after arteriovenous malformation rupture</span></h3>
<ul>
<li><span style="color: #0000ff;">Bradley A. Gross, M.D., </span></li>
<li><span style="color: #0000ff;">Pui Man Rosalind Lai, B.A., and </span></li>
<li><span style="color: #0000ff;">Rose Du, M.D., Ph.D.</span></li>
</ul>
<p></a></p>
<div>Department of Neurological Surgery, Brigham and Women&#8217;s Hospital and Harvard Medical School, Boston, Massachusetts</div>
<div><i>Abbreviations used in this paper:</i> AVM = arteriovenous malformation; EVD = external ventricular drain; GCS = Glasgow Coma Scale; IVH = intraventricular hemorrhage; mRS = modified Rankin Scale; SAH = subarachnoid hemorrhage.</div>
<div>
<div><i>Address correspondence to</i>: Rose Du, M.D., Ph.D., Department of Neurological Surgery, Brigham and Women&#8217;s Hospital and Harvard Medical School, 75 Francis Street, Boston, Massachusetts 02115. email: <a href="mailto:rdu@partners.org">rdu@partners.<wbr />org</a>.</div>
<p>Please include this information when citing this paper: DOI: 10.3171/2013.2.FOCUS12368.</p>
</div>
<div>
<div>
<div>
<h5>Related Articles</h5>
<dl>
<dt>By Keywords:</dt>
<dd><a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22arteriovenous+malformation%22%29">arteriovenous malformation</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22aneurysm%22%29">aneurysm</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22hemorrhage%22%29">hemorrhage</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22hydrocephalus%22%29">hydrocephalus</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22ventriculostomy%22%29">ventriculostomy</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22shunt%22%29">shunt</a></dd>
</dl>
</div>
</div>
</div>
<div><a name="abstract"></a></p>
<h4>Abstract</h4>
<div><a name="_i1"></a></p>
<h5>Object</h5>
<p>The rates and risk factors for external ventricular drain (EVD) placement and long-term shunt dependence in patients with ruptured arteriovenous malformations (AVMs) have not been systematically studied. In this study the authors evaluated the rates of EVD placement and shunt dependence, and risk factors for them, in a cohort of patients with ruptured AVMs.</p>
</div>
<div><a name="_i2"></a></p>
<h5>Methods</h5>
<p>The records of 87 consecutive patients with ruptured AVMs were reviewed for patient demographics, hemorrhage pattern, AVM angioarchitectural features, and surgical treatment. Univariate and multivariate logistic regression analyses were performed to evaluate risk factors for EVD placement, permanent shunt dependence, and long-term outcome (as measured by the modified Rankin Scale).</p>
</div>
<div><a name="_i3"></a></p>
<h5>Results</h5>
<p>Thirty-eight patients (44%) required EVD placement, and 16 (18%) required a permanent shunt. Statistically significant risk factors for EVD placement in the univariate analysis included initial Glasgow Coma Scale (GCS) score (p = 0.002), the presence of intraventricular hemorrhage (IVH; p &lt; 0.001), AVM-associated aneurysms (p = 0.002), and early surgery (p = 0.01). Multivariate analysis revealed only AVM-associated aneurysms as statistically significant (p = 0.006). Risk factors for shunt placement included initial GCS score (p = 0.003), IVH (p = 0.01), deep supratentorial location (p = 0.034), and associated aneurysms (p = 0.03). Multivariate analysis revealed initial GCS score as a statistically significant risk factor (p = 0.041) as well as a strong trend for associated aneurysms (p = 0.06). Patient age, sex, associated subarachnoid hemorrhage, AVM grade, AVM size, and deep venous drainage were not associated with EVD placement or long-term shunt dependence.</p>
</div>
<div><a name="_i4"></a></p>
<h5>Conclusions</h5>
<p>Hydrocephalus from AVM rupture was associated with initial GCS score, IVH, and AVM-associated aneurysms. Arteriovenous malformations with associated aneurysms thus not only have a greater risk of hemorrhage but also a greater risk of hemorrhage-associated morbidity as a result of hydrocephalus.</p>
</div>
</div>
<p>The post <a href="http://neurocirurgiabr.com/hydrocephalus-after-arteriovenous-malformation-rupture/">Hydrocephalus after arteriovenous malformation rupture</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://neurocirurgiabr.com/hydrocephalus-after-arteriovenous-malformation-rupture/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Emerging experimental therapies for intracerebral hemorrhage: targeting mechanisms of secondary brain injury</title>
		<link>http://neurocirurgiabr.com/emerging-experimental-therapies-for-intracerebral-hemorrhage-targeting-mechanisms-of-secondary-brain-injury/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=emerging-experimental-therapies-for-intracerebral-hemorrhage-targeting-mechanisms-of-secondary-brain-injury</link>
		<comments>http://neurocirurgiabr.com/emerging-experimental-therapies-for-intracerebral-hemorrhage-targeting-mechanisms-of-secondary-brain-injury/#comments</comments>
		<pubDate>Sun, 19 May 2013 14:15:27 +0000</pubDate>
		<dc:creator>Julio Pereira, MD</dc:creator>
				<category><![CDATA[Brain Trauma and NeuroCritical Care]]></category>
		<category><![CDATA[Vascular]]></category>

		<guid isPermaLink="false">http://neurocirurgiabr.com/?p=5128</guid>
		<description><![CDATA[<p>Neurosurgical Focus May 2013 / Vol. 34 / No. 5 / Page E9 Article Emerging experimental therapies for intracerebral hemorrhage: targeting mechanisms of secondary brain injury Praveen K. Belur, B.S.1, Jason J. Chang, M.D.2, Shuhan He, B.S.1, Benjamin A. Emanuel, D.O.2, and William J. Mack, M.D.3 1Keck School of Medicine, and 2Departments of Neurology, Division [...]</p><p>The post <a href="http://neurocirurgiabr.com/emerging-experimental-therapies-for-intracerebral-hemorrhage-targeting-mechanisms-of-secondary-brain-injury/">Emerging experimental therapies for intracerebral hemorrhage: targeting mechanisms of secondary brain injury</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></description>
				<content:encoded><![CDATA[<p><a href="http://thejns.org/doi/abs/10.3171/2013.2.FOCUS1317"></p>
<div>
<h2><span style="color: #0000ff;"><span style="color: #0000ff;">Neurosurgical Focus</span></span></h2>
<p><span style="color: #0000ff;"><em>May 2013</em> / Vol. 34 / No. 5 / Page E9</span></div>
<p><span style="color: #0000ff;"><strong>Article</strong></span></p>
<h3><span style="color: #0000ff;">Emerging experimental therapies for intracerebral hemorrhage: targeting mechanisms of secondary brain injury</span></h3>
<p></a></p>
<ul>
<li><a href="http://thejns.org/action/doSearch?action=search&amp;author=Belur%2C+P+K">Praveen K. Belur, B.S.<sup><sup>1</sup></sup>, </a></li>
<li><a href="http://thejns.org/action/doSearch?action=search&amp;author=Chang%2C+J+J">Jason J. Chang, M.D.<sup><sup>2</sup></sup>, </a></li>
<li><a href="http://thejns.org/action/doSearch?action=search&amp;author=He%2C+S">Shuhan He, B.S.<sup><sup>1</sup></sup>, </a></li>
<li><a href="http://thejns.org/action/doSearch?action=search&amp;author=Emanuel%2C+B+A">Benjamin A. Emanuel, D.O.<sup><sup>2</sup></sup>, and </a></li>
<li><a href="http://thejns.org/action/doSearch?action=search&amp;author=Mack%2C+W+J">William J. Mack, M.D.<sup><sup>3</sup></sup></a></li>
</ul>
<div><sup>1</sup>Keck School of Medicine, and <sup>2</sup>Departments of Neurology, Division of Neurocritical Care/Stroke, and <sup>3</sup>Neurosurgery, University of Southern California, Los Angeles, California</div>
<div><i>Abbreviations used in this paper:</i> BBB = blood-brain barrier; G-CSF = granulocyte colony-stimulating factor; ICH = intracerebral hemorrhage; MMP = matrix metalloproteinase; TNF = tumor necrosis factor.</div>
<div>
<div><i>Address correspondence to</i>: William J. Mack, M.D., 1200 North State Street, Suite 3300, Los Angeles, California 90033. email: <a href="mailto:wjmack@gmail.com">wjmack@gmail.<wbr />com</a>.</div>
<p>Please include this information when citing this paper: DOI: 10.31712013.2.FOCUS1317.</p>
</div>
<div>
<div>
<div>
<h5>Related Articles</h5>
<dl>
<dt>By Keywords:</dt>
<dd><a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22intracerebral+hemorrhage%22%29">intracerebral hemorrhage</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22secondary+brain+injury%22%29">secondary brain injury</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22pathophysiology%22%29">pathophysiology</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22therapeutic+intervention%22%29">therapeutic intervention</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22animal+model%22%29">animal model</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22neuroprotection%22%29">neuroprotection</a></dd>
</dl>
</div>
</div>
</div>
<div><a name="abstract"></a></p>
<h4>Abstract</h4>
<p>Intracerebral hemorrhage (ICH) is associated with a higher degree of morbidity and mortality than other stroke subtypes. Despite this burden, currently approved treatments have demonstrated limited efficacy. To date, therapeutic strategies have principally targeted hematoma expansion and resultant mass effect. However, secondary mechanisms of brain injury are believed to be critical effectors of cell death and neurological outcome following ICH. This article reviews the pathophysiology of secondary brain injury relevant to ICH, examines pertinent experimental models, and highlights emerging therapeutic strategies. Treatment paradigms discussed include thrombin inhibitors, deferoxamine, minocycline, statins, granulocyte-colony stimulating factors, and therapeutic hypothermia. Despite promising experimental and preliminary human data, further studies are warranted prior to effective clinical translation.</p>
</div>
<p>The post <a href="http://neurocirurgiabr.com/emerging-experimental-therapies-for-intracerebral-hemorrhage-targeting-mechanisms-of-secondary-brain-injury/">Emerging experimental therapies for intracerebral hemorrhage: targeting mechanisms of secondary brain injury</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://neurocirurgiabr.com/emerging-experimental-therapies-for-intracerebral-hemorrhage-targeting-mechanisms-of-secondary-brain-injury/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Transcranial MR-guided focused ultrasound sonothrombolysis in the treatment of intracerebral hemorrhage</title>
		<link>http://neurocirurgiabr.com/transcranial-mr-guided-focused-ultrasound-sonothrombolysis-in-the-treatment-of-intracerebral-hemorrhage/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=transcranial-mr-guided-focused-ultrasound-sonothrombolysis-in-the-treatment-of-intracerebral-hemorrhage</link>
		<comments>http://neurocirurgiabr.com/transcranial-mr-guided-focused-ultrasound-sonothrombolysis-in-the-treatment-of-intracerebral-hemorrhage/#comments</comments>
		<pubDate>Sun, 19 May 2013 14:13:52 +0000</pubDate>
		<dc:creator>Julio Pereira, MD</dc:creator>
				<category><![CDATA[Vascular]]></category>

		<guid isPermaLink="false">http://neurocirurgiabr.com/?p=5126</guid>
		<description><![CDATA[<p>Neurosurgical Focus May 2013 / Vol. 34 / No. 5 / Page E14 Article Transcranial MR-guided focused ultrasound sonothrombolysis in the treatment of intracerebral hemorrhage Stephen J. Monteith, M.D.1, Neal F. Kassell, M.D.1, Oded Goren, M.D.2, and Sagi Harnof, M.D.2 1Department of Neurosurgery, University of Virginia Health System, Charlottesville, Virginia; and 2Department of Neurosurgery, Sheba [...]</p><p>The post <a href="http://neurocirurgiabr.com/transcranial-mr-guided-focused-ultrasound-sonothrombolysis-in-the-treatment-of-intracerebral-hemorrhage/">Transcranial MR-guided focused ultrasound sonothrombolysis in the treatment of intracerebral hemorrhage</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></description>
				<content:encoded><![CDATA[<p><a href="http://thejns.org/doi/full/10.3171/2013.2.FOCUS1313"></p>
<div>
<h2><span style="color: #0000ff;">Neurosurgical Focus</span></h2>
<p><span style="color: #0000ff;"><em>May 2013</em> / Vol. 34 / No. 5 / Page E14</span></div>
<p><span style="color: #0000ff;"><strong>Article</strong></span></p>
<h3><span style="color: #0000ff;">Transcranial MR-guided focused ultrasound sonothrombolysis in the treatment of intracerebral hemorrhage</span></h3>
<p></a></p>
<ul>
<li><a href="http://thejns.org/action/doSearch?action=search&amp;author=Monteith%2C+S+J">Stephen J. Monteith, M.D.<sup><sup>1</sup></sup>, </a></li>
<li><a href="http://thejns.org/action/doSearch?action=search&amp;author=Kassell%2C+N+F">Neal F. Kassell, M.D.<sup><sup>1</sup></sup>, </a></li>
<li><a href="http://thejns.org/action/doSearch?action=search&amp;author=Goren%2C+O">Oded Goren, M.D.<sup><sup>2</sup></sup>, and </a></li>
<li><a href="http://thejns.org/action/doSearch?action=search&amp;author=Harnof%2C+S">Sagi Harnof, M.D.<sup><sup>2</sup></sup></a></li>
</ul>
<div><sup>1</sup>Department of Neurosurgery, University of Virginia Health System, Charlottesville, Virginia; and <sup>2</sup>Department of Neurosurgery, Sheba Medical Center, Tel Hashomer, Israel</div>
<div><i>Abbreviations used in this paper:</i> ICH = intracerebral hemorrhage; IVH = intraventricular hemorrhage; MRgFUS = MR-guided focused ultrasound; tPA = tissue plasminogen activator.</div>
<div>
<div><i>Address correspondence to</i>: Stephen Monteith, M.D., Department of Neurosurgery, University of Virginia Health System, P.O. Box 800212, Charlottesville, Virginia 22908. email: <a href="mailto:stephen.monteith@gmail.com">stephen.<wbr />monteith@gmail.<wbr />com</a>.</div>
<p>Please include this information when citing this paper: DOI: 10.3171/2013.2.FOCUS1313.</p>
</div>
<div>
<div>
<div>
<h5>Related Articles</h5>
<dl>
<dt>By Keywords:</dt>
<dd><a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22intracerebral+hemorrhage%22%29">intracerebral hemorrhage</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22MRgFUS%22%29">MRgFUS</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22sonothrombolysis%22%29">sonothrombolysis</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22focused+ultrasound%22%29">focused ultrasound</a>, <a href="http://thejns.org/action/doSearch?action=runSearch&amp;type=advanced&amp;result=true&amp;prevSearch=keywordsfield%3A%28%22high%5C-intensity+focused+ultrasound%22%29">high-intensity focused ultrasound</a></dd>
</dl>
</div>
</div>
</div>
<div><a name="abstract"></a></p>
<h4>Abstract</h4>
<p>Intracerebral hemorrhage remains a significant cause of morbidity and mortality. Current surgical therapies aim to use a minimally invasive approach to remove as much of the clot as possible without causing undue disruption to surrounding neural structures. Transcranial MR-guided focused ultrasound (MRgFUS) surgery is an emerging technology that permits a highly concentrated focal point of ultrasound energy to be deposited to a target deep within the brain without an incision or craniotomy. With appropriate ultrasound parameters it has been shown that MRgFUS can effectively liquefy large-volume blood clots through the human calvaria. In this review the authors discuss the rationale for using MRgFUS to noninvasively liquefy intracerebral hemorrhage (ICH), thereby permitting minimally invasive aspiration of the liquefied clot via a small drainage tube. The mechanism of action of MRgFUS sonothrombolysis; current investigational work with in vitro, in vivo, and cadaveric models of ICH; and the potential clinical application of this disruptive technology for the treatment of ICH are discussed.</p>
<p><a href="http://thejns.org/doi/full/10.3171/2013.2.FOCUS1313">http://thejns.org/doi/full/10.3171/2013.2.FOCUS1313</p>
<p></a>&nbsp;</p>
</div>
<p>The post <a href="http://neurocirurgiabr.com/transcranial-mr-guided-focused-ultrasound-sonothrombolysis-in-the-treatment-of-intracerebral-hemorrhage/">Transcranial MR-guided focused ultrasound sonothrombolysis in the treatment of intracerebral hemorrhage</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://neurocirurgiabr.com/transcranial-mr-guided-focused-ultrasound-sonothrombolysis-in-the-treatment-of-intracerebral-hemorrhage/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clinical features of brain metastasis from salivary gland tumors</title>
		<link>http://neurocirurgiabr.com/clinical-features-of-brain-metastasis-from-salivary-gland-tumors/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=clinical-features-of-brain-metastasis-from-salivary-gland-tumors</link>
		<comments>http://neurocirurgiabr.com/clinical-features-of-brain-metastasis-from-salivary-gland-tumors/#comments</comments>
		<pubDate>Sun, 19 May 2013 14:08:29 +0000</pubDate>
		<dc:creator>Julio Pereira, MD</dc:creator>
				<category><![CDATA[Brain Tumor]]></category>

		<guid isPermaLink="false">http://neurocirurgiabr.com/?p=5122</guid>
		<description><![CDATA[<p>Clinical features of brain metastasis from salivary gland tumors Publication date: Available online 16 May 2013 Source:Journal of Clinical Neuroscience Author(s): Andrew S. Venteicher , Brian P. Walcott , Sameer A. Sheth , Matija Snuderl , Anoop P. Patel , William T. Curry , Brian V. Nahed Salivary gland tumors comprise a group of 24 [...]</p><p>The post <a href="http://neurocirurgiabr.com/clinical-features-of-brain-metastasis-from-salivary-gland-tumors/">Clinical features of brain metastasis from salivary gland tumors</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></description>
				<content:encoded><![CDATA[<h3 itemprop="name">Clinical features of brain metastasis from salivary gland tumors</h3>
<div></div>
<div>Publication date: Available online 16 May 2013<br />
<b>Source:</b>Journal of Clinical Neuroscience<br />
Author(s): Andrew S. Venteicher , Brian P. Walcott , Sameer A. Sheth , Matija Snuderl , Anoop P. Patel , William T. Curry , Brian V. Nahed<br />
Salivary gland tumors comprise a group of 24 tumor subtypes with a wide range of clinical behaviors and propensities for metastasis. Several prognostic factors have been identified that help predict the development of systemic metastases, most commonly to the lung, liver, or bone. Metastases to the brain are rare. To better understand the behavior of salivary gland tumors that metastasise to the brain, we performed a retrospective cohort analysis on a series of patients to highlight features of their medical and surgical management. From 2007 to 2011, a database of 4117 elective craniotomies were queried at a single institution to identify patients surgically treated for salivary gland metastases to the brain. Three patients were identified. Histologic subtypes included salivary duct carcinoma, poorly differentiated carcinoma, and papillary mucinous adenocarcinoma. They had all undergone previous treatment for their primary malignancy. The mean time to intracranial metastasis was 48months from initial diagnosis (range, 14–91months). Treatment for intracranial metastases included surgical resection, whole brain radiation, stereotactic radiosurgery, and chemotherapy. Intracranial metastases from salivary gland tumors are rare, present years after diagnosis of the primary tumor, and are treatable with multimodality therapy.</div>
<div><a href="http://rss.sciencedirect.com/action/redirectFile?&amp;zone=main&amp;currentActivity=feed&amp;usageType=outward&amp;url=http%3A%2F%2Fwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_origin%3DIRSSSEARCH%26_method%3DcitationSearch%26_piikey%3DS0967586813001173%26_version%3D1%26md5%3Dbdd3c2ceff1f8225c2425e21c85aea2f">http://rss.sciencedirect.com/action/redirectFile?&amp;zone=main¤tActivity=feed&amp;usageType=outward&amp;url=http%3A%2F%2Fwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_origin%3DIRSSSEARCH%26_method%3DcitationSearch%26_piikey%3DS0967586813001173%26_version%3D1%26md5%3Dbdd3c2ceff1f8225c2425e21c85aea2f</a></div>
<p>The post <a href="http://neurocirurgiabr.com/clinical-features-of-brain-metastasis-from-salivary-gland-tumors/">Clinical features of brain metastasis from salivary gland tumors</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://neurocirurgiabr.com/clinical-features-of-brain-metastasis-from-salivary-gland-tumors/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Managing an Online Reputation</title>
		<link>http://neurocirurgiabr.com/managing-an-online-reputation/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=managing-an-online-reputation</link>
		<comments>http://neurocirurgiabr.com/managing-an-online-reputation/#comments</comments>
		<pubDate>Thu, 16 May 2013 16:36:41 +0000</pubDate>
		<dc:creator>Julio Pereira, MD</dc:creator>
				<category><![CDATA[Education]]></category>

		<guid isPermaLink="false">http://neurocirurgiabr.com/?p=5108</guid>
		<description><![CDATA[<p>Managing an Online Reputation Zusman, Edie E. Neurosurgery 72:4:N11–N14, 2013. doi: 10.1227/01.neu.0000428419.97328.67 Link to free article. A physician&#8217;s reputation has always been key to success or failure in medical practice. Good publicity helps build a physician&#8217;s renown, patient base, loyalty and standing in the community. &#8230; To continue read CLICK HERE &#160; &#160;</p><p>The post <a href="http://neurocirurgiabr.com/managing-an-online-reputation/">Managing an Online Reputation</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></description>
				<content:encoded><![CDATA[<h2>Managing an Online Reputation</h2>
<p>Zusman, Edie E.</p>
<p>Neurosurgery 72:4:N11–N14, 2013. doi: 10.1227/01.neu.0000428419.97328.67</p>
<p><span style="color: #0000ff;"><a href="http://journals.lww.com/neurosurgery/Fulltext/2013/04000/Managing_an_Online_Reputation.1.aspx" target="_blank"><span style="color: #0000ff;">Link to free article.</span></a></span></p>
<p>A physician&#8217;s reputation has always been key to success or failure in medical practice. Good publicity helps build a physician&#8217;s renown, patient base, loyalty and standing in the community.</p>
<p>&#8230;</p>
<p><span style="color: #0000ff;"><a href="http://journals.lww.com/neurosurgery/Fulltext/2013/04000/Managing_an_Online_Reputation.1.aspx"><span style="color: #0000ff;">To continue read CLICK HERE</span></a></span></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>The post <a href="http://neurocirurgiabr.com/managing-an-online-reputation/">Managing an Online Reputation</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://neurocirurgiabr.com/managing-an-online-reputation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The role of anticoagulants, antiplatelet agents, and their reversal strategies in the management of intracerebral hemorrhage</title>
		<link>http://neurocirurgiabr.com/the-role-of-anticoagulants-antiplatelet-agents-and-their-reversal-strategies-in-the-management-of-intracerebral-hemorrhage/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-role-of-anticoagulants-antiplatelet-agents-and-their-reversal-strategies-in-the-management-of-intracerebral-hemorrhage</link>
		<comments>http://neurocirurgiabr.com/the-role-of-anticoagulants-antiplatelet-agents-and-their-reversal-strategies-in-the-management-of-intracerebral-hemorrhage/#comments</comments>
		<pubDate>Thu, 16 May 2013 16:26:41 +0000</pubDate>
		<dc:creator>Julio Pereira, MD</dc:creator>
				<category><![CDATA[Vascular]]></category>

		<guid isPermaLink="false">http://neurocirurgiabr.com/?p=5103</guid>
		<description><![CDATA[<p>The role of anticoagulants, antiplatelet agents, and their reversal strategies in the management of intracerebral hemorrhage Robert F. James, M.D., Viktoras Palys, M.D., Jason R. Lomboy, B.A., J. Richard Lamm Jr., B.S., and Scott D. Simon, M.D. Neurosurgical Focus 34:5:E6, 2013 Link to free article. &#160; New anticoagulant and antiplatelet medications have been approved and [...]</p><p>The post <a href="http://neurocirurgiabr.com/the-role-of-anticoagulants-antiplatelet-agents-and-their-reversal-strategies-in-the-management-of-intracerebral-hemorrhage/">The role of anticoagulants, antiplatelet agents, and their reversal strategies in the management of intracerebral hemorrhage</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></description>
				<content:encoded><![CDATA[<h2><a href="http://www.neurosurgic.com/index.php?option=com_content&amp;view=article&amp;id=2140:the-role-of-anticoagulants-antiplatelet-agents-and-their-reversal-strategies-in-the-management-of-intracerebral-hemorrhage&amp;catid=297:neurosurgical-focus&amp;Itemid=360"> The role of anticoagulants, antiplatelet agents, and their reversal strategies in the management of intracerebral hemorrhage </a></h2>
<p>Robert F. James, M.D., Viktoras Palys, M.D., Jason R. Lomboy, B.A., J. Richard Lamm Jr., B.S., and Scott D. Simon, M.D.</p>
<p>Neurosurgical Focus 34:5:E6, 2013</p>
<p><a href="http://thejns.org/doi/full/10.3171/2013.2.FOCUS1328" target="_blank">Link to free article.</a></p>
<p>&nbsp;</p>
<p>New anticoagulant and antiplatelet medications have been approved and are prescribed with increased frequency. Intracranial hemorrhage is associated with the use of these medications. Therefore, neurosurgeons need to be aware of these new medications, how they are different from their predecessors, and the strategies for the urgent reversal of their effects. Utilization of intraluminal stents by endovascular neurosurgeons has resulted in the need to have a thorough understanding of antiplatelet agents. Increased use of dabigatran, rivaroxaban, and apixaban as oral anticoagulants for the treatment of atrial fibrillation and acute deep venous thrombosis has increased despite the lack of known antidotes to these medications.</p>
<p>The post <a href="http://neurocirurgiabr.com/the-role-of-anticoagulants-antiplatelet-agents-and-their-reversal-strategies-in-the-management-of-intracerebral-hemorrhage/">The role of anticoagulants, antiplatelet agents, and their reversal strategies in the management of intracerebral hemorrhage</a> appeared first on <a href="http://neurocirurgiabr.com">NEUROSURGERY BLOG</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://neurocirurgiabr.com/the-role-of-anticoagulants-antiplatelet-agents-and-their-reversal-strategies-in-the-management-of-intracerebral-hemorrhage/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
